Main Story
-
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options. Clinical activity observed in a heavily pretreated population: clinical activity was observed in a population with a median of…
Editor’s Picks
Editor’s Picks
Trending Now
Featured News
Cover Stories
-
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options. Clinical activity observed in a heavily pretreated population: clinical activity was observed in a population with a median of…
-
Gastops and Anschütz to Collaborate on Canadian Patrol Submarine Project Sustainment
PARIS , Nov. 4, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring, predictive maintenance and advanced in-service support solutions, and Anschütz, a leading provider of submarine mission systems, automation, control and navigation solutions for naval platforms, have signed a Memorandum of Understanding (MoU) to collaborate on integration, testing, diagnostics, and sustainment activities for…
Popular Now
-
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options. Clinical activity observed in a heavily pretreated population: clinical activity was observed in a population with a median of…
-
Gastops and Anschütz to Collaborate on Canadian Patrol Submarine Project Sustainment
PARIS , Nov. 4, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring, predictive maintenance and advanced in-service support solutions, and Anschütz, a leading provider of submarine mission systems, automation, control and navigation solutions for naval platforms, have signed a Memorandum of Understanding (MoU) to collaborate on integration, testing, diagnostics, and sustainment activities for…
Cover Stories
Popular Now
Must Read
-
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options. Clinical activity observed in a heavily pretreated population: clinical activity was observed in a population with a median of…
-
Gastops and Anschütz to Collaborate on Canadian Patrol Submarine Project Sustainment
PARIS , Nov. 4, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring, predictive maintenance and advanced in-service support solutions, and Anschütz, a leading provider of submarine mission systems, automation, control and navigation solutions for naval platforms, have signed a Memorandum of Understanding (MoU) to collaborate on integration, testing, diagnostics, and sustainment activities for…
-
Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
SAN FRANCISCO, Nov. 4, 2026 /PRNewswire/ — Redis today announced the next chapter of Redis Iris, its real-time context engine for AI agents. Redis Iris now offers six customizable capabilities designed to be used together or independently, that give agents the memory, context, and messaging they need to work reliably in the real world: Redis…
-
Agthia Reports Revenue Growth Amid Challenging Cost Environment
ABU DHABI, UAE, Nov. 4, 2026 /PRNewswire/ — Agthia Group PJSC (AGTHIA:UH), one of the region’s leading food and beverage companies, today reported its results for the third quarter and first nine months of 2026. Group Financial Performance Agthia’s growth accelerated in the third quarter, with reported earnings rising well ahead of the top line,…
-
Puri-Bhubaneswar Highway Set for Six-Laning; Soil Testing Begins, 45-Minute Journey in Focus
Bhubaneswar, Nov 4 (UDN): The proposed expansion of the Puri-Bhubaneswar National Highway into a six-lane corridor has taken its first step, with soil testing underway at key locations along the route. The ambitious infrastructure project aims to ease chronic traffic congestion and reduce travel time between the two cities to approximately 45 minutes. Representational Image …
-
India, Nepal Review Bilateral Ties Ahead of PM Balendra Shah’s Proposed Visit
Kathmandu, Nov 4: India and Nepal on Wednesday held a series of high-level discussions to strengthen bilateral relations and advance cooperation across key sectors, as Indian Foreign Secretary Vikram Misri began a two-day visit to Kathmandu ahead of Nepali Prime Minister Balendra Shah’s proposed trip to New Delhi later this month. Misri met Nepal’s Foreign…
Recommended News
-
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell non-Hodgkin lymphoma (B-NHL) who have exhausted available standard treatment options. Clinical activity observed in a heavily pretreated population: clinical activity was observed in a population with a median of…
-
Gastops and Anschütz to Collaborate on Canadian Patrol Submarine Project Sustainment
PARIS , Nov. 4, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring, predictive maintenance and advanced in-service support solutions, and Anschütz, a leading provider of submarine mission systems, automation, control and navigation solutions for naval platforms, have signed a Memorandum of Understanding (MoU) to collaborate on integration, testing, diagnostics, and sustainment activities for…
-
Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
SAN FRANCISCO, Nov. 4, 2026 /PRNewswire/ — Redis today announced the next chapter of Redis Iris, its real-time context engine for AI agents. Redis Iris now offers six customizable capabilities designed to be used together or independently, that give agents the memory, context, and messaging they need to work reliably in the real world: Redis…
-
Agthia Reports Revenue Growth Amid Challenging Cost Environment
ABU DHABI, UAE, Nov. 4, 2026 /PRNewswire/ — Agthia Group PJSC (AGTHIA:UH), one of the region’s leading food and beverage companies, today reported its results for the third quarter and first nine months of 2026. Group Financial Performance Agthia’s growth accelerated in the third quarter, with reported earnings rising well ahead of the top line,…
-
Puri-Bhubaneswar Highway Set for Six-Laning; Soil Testing Begins, 45-Minute Journey in Focus
Bhubaneswar, Nov 4 (UDN): The proposed expansion of the Puri-Bhubaneswar National Highway into a six-lane corridor has taken its first step, with soil testing underway at key locations along the route. The ambitious infrastructure project aims to ease chronic traffic congestion and reduce travel time between the two cities to approximately 45 minutes. Representational Image …
Latest News
You May Have Missed
